Rx May Boost Bleeding in Obese Patients
Obesity is tied to many health issues, and new evidence suggests that obese patients may face another health risk when taking a common blood thinner.
Menopause Rx: The Heart of the Matter
The use of hormones during menopause was once thought to protect against heart disease, but that may not be the case.
FDA Approves Farydak for Treatment of Multiple Myeloma
The U.S. Food and Drug Administration today approved Farydak (panobinostat) for the treatment of patients with multiple myeloma.
How Fish Might Affect Your Immune Health
Seafood is always a great choice for protein if you’re young and female, right? Not so fast.
Blood Donor? Check Your Iron Levels
Giving blood can be a selfless act that can save lives, but it may also affect the donor's health if it's done too frequently.
First Drug Approved to Treat Waldenström’s Macroglobulinemia
The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) for patients with Waldenström’s macroglobulinemia (WM), a rare form of cancer that begins in the body’s immune system.
New Rx Approved for Low Blood Calcium
The U.S. Food and Drug Administration approved Natpara (parathyroid horomone) to control hypocalcemia (low blood calcium levels) in patients with hypoparathyroidism, a rare disease that affects approximately 60,000 people in the United States.
Great Leaps in Leukemia Treatment
Cancer research has led to longer lives and better quality of life for millions of people. This year, the transformation of leukemia treatment has been singled out as the “Advance of the Year.”
FDA Approves Anti-Clotting Drug Savaysa
The U.S. Food and Drug Administration today approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.
FDA Approves Pathogen Reduction System to Treat Platelets
The U.S. Food and Drug Administration yesterday approved the Intercept Blood System for platelets, the first pathogen reduction system to treat single donor apheresis platelets.